Skip to main content
. 2020 Nov 18;12(2):218–226. doi: 10.1111/1759-7714.13748

Figure 2.

Figure 2

The expression of PD‐L1 and infiltration of CD4+, CD8+ T cells within NSCLC patients harboring Ex20ins of EGFR or HER2. NSCLC tumors with EGFR Ex20ins: (a) Positive expression of PD‐L1; (b) presence of CD4+ TILs; (c) presence of CD8+ TILs. NSCLC tumors with HER2 Ex20ins: (d) Positive expression of PD‐L1; (e) presence of CD4+ TILs; and (f) presence of CD8+ TILs. (*200).